Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

NF-κB Signaling in Ovarian Cancer
Brittney S. Harrington, Christina M. Annunziata
Cancers (2019) Vol. 11, Iss. 8, pp. 1182-1182
Open Access | Times Cited: 101

Showing 1-25 of 101 citing articles:

Chemotherapy: a double-edged sword in cancer treatment
Nafiseh Behranvand, Farzad Nasri, Reza Zolfaghari Emameh, et al.
Cancer Immunology Immunotherapy (2021) Vol. 71, Iss. 3, pp. 507-526
Open Access | Times Cited: 220
Exploring the Emerging Role of the Gut Microbiota and Tumor Microenvironment in Cancer Immunotherapy
Qin Qiu, Yuqi Lin, Yucui Ma, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 107
Applications of Proteomics in Ovarian Cancer: Dawn of a New Era
Aruni Ghose, Sri Vidya Niharika Gullapalli, Naila Chohan, et al.
Proteomes (2022) Vol. 10, Iss. 2, pp. 16-16
Open Access | Times Cited: 103
Drug resistance in ovarian cancer: from mechanism to clinical trial
Ling Wang, Xin Wang, Xueping Zhu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 54
Roles of microRNAs in Ovarian Cancer Tumorigenesis: Two Decades Later, What Have We Learned?
Ali A. Alshamrani
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 76
Targeting the NF-κB Pathway for Therapy of Ischemic Stroke
John Aaron Howell, Gene L. Bidwell
Therapeutic Delivery (2020) Vol. 11, Iss. 2, pp. 113-123
Closed Access | Times Cited: 72
Tumor-Associated Macrophages and Ovarian Cancer: Implications for Therapy
David Schweer, Annabel M. McAtee, Khaga R. Neupane, et al.
Cancers (2022) Vol. 14, Iss. 9, pp. 2220-2220
Open Access | Times Cited: 69
Targeting ovarian cancer stem cells: a new way out
Huiying Ma, Tian Tian, Zhumei Cui
Stem Cell Research & Therapy (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 32
AEBP1 is a Novel Oncogene: Mechanisms of Action and Signaling Pathways
Amin F. Majdalawieh, Mariam Massri, Jungsil Ro
Journal of Oncology (2020) Vol. 2020, pp. 1-20
Open Access | Times Cited: 62
SnapShot: TP53 status and macrophages infiltration in TCGA-analyzed tumors
Amr Ahmed El–Arabey, Mohnad Abdalla, Adel R. A. Abd‐Allah
International Immunopharmacology (2020) Vol. 86, pp. 106758-106758
Closed Access | Times Cited: 54
NF-κB Signaling in Tumor Pathways Focusing on Breast and Ovarian Cancer
Monika Devanaboyina, Jasskiran Kaur, Emma Whiteley, et al.
Oncology Reviews (2022) Vol. 16
Open Access | Times Cited: 38
Intrinsic and Extrinsic Factors Impacting Cancer Stemness and Tumor Progression
A. O. Ponomarev, Zarema E. Gilazieva, Valeriya V. Solovyeva, et al.
Cancers (2022) Vol. 14, Iss. 4, pp. 970-970
Open Access | Times Cited: 33
Therapeutic potential of melatonin in glioblastoma: Current knowledge and future prospects
Nithar Ranjan Madhu, Bhanumati Sarkar, Paramita Biswas, et al.
Elsevier eBooks (2024), pp. 371-386
Closed Access | Times Cited: 7
Unraveling molecular signatures in rare bone tumors and navigating the cancer pathway landscapes for targeted therapeutics
Atif Khurshid Wani, Ajit Prakash, Saikat Sena, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 196, pp. 104291-104291
Closed Access | Times Cited: 7
Association between dietary intake and risk of ovarian cancer: a systematic review and meta-analysis
Alireza Khodavandi, Fahimeh Alizadeh, Ahmad Faizal Abdull Razis
European Journal of Nutrition (2020) Vol. 60, Iss. 4, pp. 1707-1736
Closed Access | Times Cited: 42
Insights into the Role of Oxidative Stress in Ovarian Cancer
Dan‐Ni Ding, Liangzhen Xie, Ying Shen, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 41
MicroRNA miR-330-3p suppresses the progression of ovarian cancer by targeting RIPK4
Cai Li, Lü Y, Xiaoqing Hu, et al.
Bioengineered (2021) Vol. 12, Iss. 1, pp. 440-449
Open Access | Times Cited: 40
The role of Toll-like receptor 4 signaling pathway in ovarian, cervical, and endometrial cancers
Luiz Antônio Lupi, Maira Smaniotto Cucielo, Henrique Spaulonci Silveira, et al.
Life Sciences (2020) Vol. 247, pp. 117435-117435
Closed Access | Times Cited: 39
Hsa_circ_0009910: oncogenic circular RNA targets microRNA-145 in ovarian cancer cells
Ying Li, Shuang Lin, Na An
Cell Cycle (2020) Vol. 19, Iss. 15, pp. 1857-1868
Open Access | Times Cited: 33
Ganetespib with Methotrexate Acts Synergistically to Impede NF-κB/p65 Signaling in Human Lung Cancer A549 Cells
Gehad M. Subaiea, Syed Mohd Danish Rizvi, Vikash Kumar Yadav, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 2, pp. 230-230
Open Access | Times Cited: 13
Curcumol, a major terpenoid from Curcumae Rhizoma, attenuates human uterine leiomyoma cell development via the p38MAPK/NF-κB pathway
Yonghui Yu, Haojun Zhang, Fang Yang, et al.
Journal of Ethnopharmacology (2023) Vol. 310, pp. 116311-116311
Closed Access | Times Cited: 13
Effects of saponins from Chinese herbal medicines on signal transduction pathways in cancer: A review
Mingtao Zhu, Yanping Sun, Haodong Bai, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 12
Baicalin, a Potent Inhibitor of NF-κB Signaling Pathway, Enhances Chemosensitivity of Breast Cancer Cells to Docetaxel and Inhibits Tumor Growth and Metastasis Both In Vitro and In Vivo
Anqi Zeng, Xin Liang, Shaomi Zhu, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 30
Inflammatory cytokines as key players of apoptosis induced by environmental estrogens in the ovary
Fa‐Li Zhang, Li Kong, Ai‐Hong Zhao, et al.
Environmental Research (2021) Vol. 198, pp. 111225-111225
Closed Access | Times Cited: 27
Utilizing Patient-Derived Epithelial Ovarian Cancer Tumor Organoids to Predict Carboplatin Resistance
J Górski, Zhuwei Zhang, J. Robert McCorkle, et al.
Biomedicines (2021) Vol. 9, Iss. 8, pp. 1021-1021
Open Access | Times Cited: 26
Page 1 - Next Page

Scroll to top